NFKB1 and inflammatory bowel disease: Another study showed the therapeutic potential of lentinan in mouse models of IBD and CAC; lentinan exerts its beneficial effect in mice with IBD and CAC possibly by inhibiting TLR4/NF-κB signalling and the expression of colon cancer markers.